Nyrada

Media


 
    Biotech Dispatch: Nyrada reports 'encouraging' early efficacy results from PCSK9i program  

Australian biotech news website, BiotechDispatch said Nyrada had reported "encouraging efficacy results" from an in vivo study involving its NYX-PCSK9i drug candidate.

Read more here

 
    Nyrada (ASX: NYR) CEO James Bonnar discusses the company‚Äôs commercialisation plans  
 
    Hypercholesterolaemia Drug Candidate Animation  
 
    Nyrada Brain Injury Explainer Animation